Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,241 to 1,260 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MCL-1 is a clinically targetable vulnerability in breast cancer. | Cell Cycle | 2022 | 35349392 | PubTator, text mining | PubMed |
| Development of an LC-MS/MS Method for ARV-110, a PROTAC Molecule, and Applications to Pharmacokinetic Studies. | Molecules | 2022 | 35335338 | PubTator, text mining | PubMed |
| Uncovering post-translational modification-associated protein-protein interactions. | Curr Opin Struct Biol | 2022 | 35334254 | PubTator, text mining | PubMed |
| Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias. | J Hematol Oncol | 2022 | 35331314 | PubTator, text mining | PubMed |
| Roles of Cullin-RING Ubiquitin Ligases in Cardiovascular Diseases. | Biomolecules | 2022 | 35327608 | PubTator, text mining | PubMed |
| Targeting CDK4/6 for Anticancer Therapy. | Biomedicines | 2022 | 35327487 | PubTator, text mining | PubMed |
| From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance. | Cancers (Basel) | 2022 | 35326711 | PubTator, text mining | PubMed |
| Modulation of Cellular Redox Parameters for Improving Therapeutic Responses in Multiple Myeloma. | Antioxidants (Basel) | 2022 | 35326105 | PubTator, text mining | PubMed |
| Boron clusters as broadband membrane carriers. | Nature | 2022 | 35322251 | PubTator, text mining | PubMed |
| Caspase-8: Friend or Foe in Bortezomib/Lenalidomide-Based Therapy for Myeloma. | Front Oncol | 2022 | 35321428 | PubTator, text mining | PubMed |
| Functional interactomes of the Ebola virus polymerase identified by proximity proteomics in the context of viral replication. | Cell Rep | 2022 | 35320713 | PubTator, text mining | PubMed |
| Discovery and Optimization of Tau Targeted Protein Degraders Enabled by Patient Induced Pluripotent Stem Cells-Derived Neuronal Models of Tauopathy. | Front Cell Neurosci | 2022 | 35317195 | PubTator, text mining | PubMed |
| Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders. | Nat Rev Drug Discov | 2022 | 35314852 | PubTator, text mining | PubMed |
| Hijacking Methyl Reader Proteins for Nuclear-Specific Protein Degradation. | J Am Chem Soc | 2022 | 35311258 | PubTator, text mining | PubMed |
| The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism. | Cancer Cell Int | 2022 | 35307036 | PubTator, text mining | PubMed |
| BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma. | Cell Biosci | 2022 | 35303940 | PubTator, text mining | PubMed |
| Altered pathways and targeted therapy in double hit lymphoma. | J Hematol Oncol | 2022 | 35303910 | PubTator, text mining | PubMed |
| Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells. | ACS Synth Biol | 2022 | 35302756 | PubTator, text mining | PubMed |
| Development of Potent and Selective Janus Kinase 2/3 Directing PG-PROTACs. | ACS Med Chem Lett | 2022 | 35300081 | PubTator, text mining | PubMed |
| Profiling of diverse tumor types establishes the broad utility of VHL-based ProTaCs and triages candidate ubiquitin ligases. | iScience | 2022 | 35295813 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=63